24. Februar 2025 – On 6 February 2025 vVARDIS group, a Swiss based developer and manufacturer of dental products under the Curodont brand, closed a secured financing from OrbiMed, a leading investor in the healthcare industry.

Walder Wyss advised the funds managed by OrbiMed Advisors LLC. The team was led by Tervel Stoyanov (Counsel, Banking & Finance) and further included Marion Bähler (Partner, Corporate / M&A), Maurus Winzap (Partner, Tax), Ursina Gremminger (Managing Associate, Tax), Hugh Reeves (Partner, IP) and Jérôme Heman (Associate, Banking & Finance).